Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Mainz Biomed B.V. (MYNZ)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
6.89-0.09 (-1.22%)
At close: 03:54PM EDT
6.89 -0.01 (-0.07%)
After hours: 04:49PM EDT
Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Sept. 30.

Sign in to post a message.
  • B
    Blazing
    $MYNZ News September 28, 2022

    Mainz Biomed Strengthens Board of Directors with Nomination of Dr. Heiner Dreismann and Gregory Tibbitts https://finance.yahoo.com/news/mainz-biomed-strengthens-board-directors-110000523.html
    Bullish
  • B
    Blazing
    Pipeline - Another Key Pipeline Product Could Detect What May Become The World’s Second Most Deadly Cancer $MYNZ
    https://investorbrandmedia.com/mynz-stock-alert/
    Investor Brand Media Profile Alert – Investor Brand Media
    investorbrandmedia.com
    Bullish
  • B
    Blazing
    $MYNZ Flagship product ColoAlert...
    *Announced receiving supportive feedback from the FDA on ColoAlert's pre-submission package
    *Initiating and enrolling the first patient in an international clinical study (ColoFuture)
    *Evaluating the integration of novel mRNA biomarkers into ColoAlert.
    https://www.marketwatch.com/press-release/mainz-biomed-targets-multi-billion-dollar-sales-opportunities-with-best-in-class-cancer-screening-diagnostics-mynz-2022-09-26
    Bullish
  • B
    Blazing
    $MYNZ Article September 26, 2022

    There’s No Doubt About It, Early Detection Saves Lives Mainz Biomed N.V. (NASDAQ:MYNZ)
    https://investorbrandmedia.com/mynz-stock-alert/
    Bullish
  • B
    Blazing
    $MYNZ - ColoAlert, a blockbuster early detection test for colorectal cancer, makes Bowel Cancer screening simple, fast, and precise.
    Bullish
  • B
    Blazing
    $MYNZ - Established partnership with Dante Labs to market ColoAlert in Italy and the United Arab Emirates.
    https://finance.yahoo.com/news/mainz-biomed-reports-first-half-070100420.html
    Bullish
  • B
    Blazing
    $MYNZ also has a product in the pipeline called Pancalert that is intended to detect pancreatic cancer cases early! The company is currently developing proprietary genetic testing methods for pancreatic cancer.
    Bullish
  • C
    Cafefairy
    This is the next biontech
    Bullish
  • B
    Bud
    $MYNZ their flagship product (ColoAlert) could become an inexpensive alternative in a $3.7 billion market https://www.l3opptrk.com/3J67C1/3T3PPKJ/
    Bullish
  • D
    Dan F
    This one is hitting the scanners... What's the story? And where is the volume? Looks like nobody wants to touch this in any direction...
    Neutral
  • J
    Junk
    Boustead IPO now over 3x offering price, what could go wrong?
  • D
    Dan
    This is going in the wrong direction
  • N
    Nikolaus
    Watch the Video from 5:08 onwards ... here CEO of MYNZ explains, why the business model of MYNZ is better than that of $EXAS: If you make the test from EXAS then this test can only be analyzed in one, I repeat one, central laboratory in the United States. So every test around the world needs to be sent to this laboratory.

    Now MYNZ ColoAlert test can be analyzed in ANY laboratory in the world! Imagine what that means:
    As Guido says in the video, they are providing those tests to the laboratories, and guess what: They are selling those tests. Since more laboratories are incentivized to sell ColoAlert test kits, the selling power should be much better.

    And for clients, it is more convenient to send it to a laboratory close to them and not to the United States's central laboratory.

    If you don't believe me, watch the Vid from 5:08 minutes onwards.

    https://www.youtube.com/watch?v=t6I-qJmKo5Q
    Detect Cancer Early & Increase Survival Rate Significantly | Mainz Biomed $MYNZ
    www.youtube.com
  • O
    Otan
    This might be a multibagger
  • B
    Bud
    $BBBT conversation
    $MYNZ a $3.7 Billion Market Opportunity https://www.l3opptrk.com/3J67C1/3T3PPKJ/
    Bullish
  • w
    wehling
    I just got a tip about MYZN from (http://traderspot.club). What do you guys think?
  • B
    Blazing
    WHAT COULD FDA APPROVAL MEAN FOR MAINZ BIOMED (NASDAQ: MYNZ) AND ITS NEW BLOCKBUSTER EARLY DETECTION TEST?
    Bullish
  • G
    Go
    Wow, the heaven for shorts. Today is the last green day and next go back to close the gap at 10.75. Very easy.
    Bearish
Advertisement
Advertisement